Physician profile
William M Goodman
NPI 1689760670
$1,899.79
in general payments reported to CMS, 2019-2025
8 companies · $841 in 2025
The $841 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.05 · 2020: $20.77 · 2021: $138 · 2022: $83.45 · 2023: $104 · 2024: $652 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,597.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,082.78 | 2019-2025 | Clareon, Clareon Panoptix Pro |
| Glaukos Corporation | $335.19 | 2020-2025 | Idosetr |
| Rxsight INC | $225.68 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Johnson & Johnson Surgical Vision, INC. | $174.68 | 2021-2025 | Tecnis Iol |
| Mallinckrodt Enterprises LLC | $32.85 | 2019 | |
| Abbvie INC. | $18.90 | 2024 | |
| Allergan, INC. | $18.56 | 2022 | |
| Omeros Corporation | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.